Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20088935 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)
Condition: Thromboembolism
Intervention: Drug: YM150

Study has passed its completion date and status has not been verified in more than two years.